Key Finding
Acupuncture achieved a 57.9% composite response rate for IBS-D symptoms compared to 41.4% with sham treatment, with benefits sustained over 18 weeks and no serious adverse events.
A new study from China offers promising news for people suffering from irritable bowel syndrome with diarrhea (IBS-D). Researchers tested whether acupuncture could help reduce the uncomfortable symptoms that affect roughly 4% of adults and often persist despite standard treatments.
The study involved 280 patients across six hospitals who were randomly assigned to receive either real acupuncture or sham acupuncture (using blunt-tipped needles at non-treatment points). Both groups received 15 treatment sessions over six weeks, then were followed for an additional 12 weeks.
The results were significant. After six weeks, nearly 58% of patients receiving real acupuncture experienced meaningful improvement—defined as at least 30% reduction in abdominal pain and 50% fewer days with diarrhea—compared to 41% in the sham group. The benefits started appearing by week three and lasted throughout the 18-week study period, with only one brief exception at week 16.
Importantly, no serious side effects were reported, suggesting acupuncture is a safe option for IBS-D. Patients experienced improvements in both pain levels and stool consistency, two of the most troublesome symptoms of this condition.
For the millions who continue experiencing IBS-D symptoms despite trying dietary changes, fiber supplements, and medications, this study suggests acupuncture could be a valuable alternative or complementary treatment. The sustained benefits lasting several months after treatment is particularly encouraging, as IBS is typically a chronic condition requiring long-term management.
If you're considering acupuncture for IBS-D, seek out a licensed acupuncturist with experience treating digestive disorders.
This multicenter RCT from six Chinese hospitals evaluated acupuncture efficacy for diarrhea-predominant IBS (IBS-D) using Rome IV diagnostic criteria. 280 patients aged 18-75 were randomized 1:1 to receive 15 sessions of acupuncture versus sham acupuncture (blunt-tipped needles at non-acupoints) over six weeks, with 12-week follow-up.
The primary composite endpoint—≥30% improvement in worst abdominal pain plus ≥50% reduction in diarrhea days at week 6—was achieved by 57.9% of acupuncture patients versus 41.4% of controls (RR 1.40; P=0.008). Between-group differences emerged at week 3 and persisted through week 18, except at week 16. Secondary outcomes showed improvements in both abdominal pain and stool consistency. No severe adverse events occurred.
Clinical significance: This rigorously designed trial demonstrates acupuncture provides clinically meaningful, sustained benefit for IBS-D patients who often remain symptomatic with conventional therapies. The sustained efficacy beyond treatment cessation supports acupuncture as a viable therapeutic option for IBS-D management.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.